Locations:
Search IconSearch

Research

19-NEU-3933-epilepsy-genetics-650×450
October 25, 2019/Genomic Medicine

A Genetic Risk Score for Common Epilepsy Types

Largest study of epilepsy genetics identifies polygenic risk score

19-NEU-3980-sleep-apnea_650x450
October 7, 2019/Neurosciences/Research

Obstructive Sleep Apnea: How Do the Leading Therapies Stack Up in Effects on Sleepiness and Blood Pressure?

Retrospective clinic-based study provides intriguing initial comparisons

19-NEU-3979-relapsing-multiple-sclerosis-650×450
September 24, 2019/Neurosciences/Research

Phase 3 Ozanimod Trials Show Good Efficacy and Tolerability at 2 Years for Relapsing MS

Findings hint at potentially easier treatment initiation vs. other S1P receptor modulators

19-NEU-3935-myelin-PET-650×450

New Myelin Imaging Strategy to Refine MS Diagnosis and Monitoring Garners $1.6M NIH Grant

Benefits of novel PET radiotracer expected to go beyond multiple sclerosis

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-NEU-3925-stereotactic-radiosurgery-brain-mets-650×450
September 16, 2019/Cancer

High-Dose Neoadjuvant Radiosurgery for Brain Metastases Appears Safe, Effective in Early Results from Phase 1/2 Study

Dose-escalation trial shows local control with low toxicity, low leptomeningeal recurrence

Figure7
September 10, 2019/Neurosciences/Research

Augmented Reality System for Evaluating Post-mTBI Combat Readiness Promises Clinical Payoffs Too

DoD grant supports creation, validation of multidimensional field assessments

18-NEU-5689 Alzheimers-brain-650×450
August 22, 2019/Geriatrics

Lenalidomide for Early Alzheimer’s: Taking on Multiple Neuropathologies at Once

New clinical trials size up an immunomodulator’s pleiotropic effects

19-NEU-3900-immunotherapy-650×450
August 20, 2019/Cancer

Immunotherapy for Non-Small Cell Lung Cancer Brain Metastases: Ready for Prime Time

Companion studies reveal efficacy indicators for PD-1/PD-L1 inhibition

19-NEU-463-epilepsy-650×450

Integrated Studies Focus in on Optimal Prediction of Epilepsy Treatment Response

Grant enables pooling of genomics, molecular medicine, animal models, advanced neuroimaging

BackPage 7 of 21Next

Advertisement

Ad